Idexx LaboratoriesIDXX
Market Cap: $38.9B
About: Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
Employees: 11,000
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
2.92% more ownership
Funds ownership: 87.63% [Q1] → 90.55% (+2.92%) [Q2]
8% more repeat investments, than reductions
Existing positions increased: 407 | Existing positions reduced: 377
4% less funds holding
Funds holding: 1,123 [Q1] → 1,081 (-42) [Q2]
7% less capital invested
Capital invested by funds: $39.2B [Q1] → $36.4B (-$2.82B) [Q2]
28% less call options, than puts
Call options by funds: $106M | Put options by funds: $148M
33% less funds holding in top 10
Funds holding in top 10: 21 [Q1] → 14 (-7) [Q2]
34% less first-time investments, than exits
New positions opened: 81 | Existing positions closed: 123
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
Piper Sandler David Westenberg 55% 1-year accuracy 16 / 29 met price target | 10%upside $520 | Neutral Maintained | 14 Aug 2024 |
BTIG Mark Massaro 63% 1-year accuracy 17 / 27 met price target | 23%upside $580 | Buy Initiated | 25 Jul 2024 |
Stifel Jonathan Block 50% 1-year accuracy 13 / 26 met price target | 8%upside $510 | Hold Maintained | 24 Jun 2024 |
Financial journalist opinion
Based on 3 articles about IDXX published over the past 30 days